Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Inspira Technologies VORTX Device A Groundbreaking Advancement in Blood Oxygenation Technology

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
IT-Healthcare
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Inspira Technologies has made a groundbreaking achievement with its VORTX™ device on March 12, 2024, demonstrating exceptional performance in blood oxygenation and carbon dioxide removal. The device has successfully met all regulatory guidelines for blood oxygenation at various flow rates, maintaining a zero pressure gradient across the blood, leading to a decrease in markers of blood damage.

This significant milestone represents a major leap forward in the development of safer and more effective medical devices aimed at enhancing patient safety and improving clinical outcomes. Moreover, the VORTX™ technology has been granted a U.S. patent with 94% of its claims considered novel, highlighting its innovative approach to blood oxygenation that eliminates the need for fiber membranes and maintains crucial zero pressure gradient levels to minimize mechanical shear stress and reduce damage to blood components.

Inspira Technologies’ development of the VORTX™ Blood Oxygenator signifies a groundbreaking advancement in acute respiratory care, with the potential to revolutionize the perfusionist systems market valued at $1.16 billion. This cutting-edge technology is designed to efficiently saturate blood with oxygen and remove carbon dioxide, potentially enhancing hemodynamic performance and reducing oxygenator failure compared to traditional membrane-based systems.

In conclusion, Inspira Technologies’ VORTX™ device represents remarkable progress in medical technology, offering a promising solution for improving patient care and clinical outcomes through its innovative approach to blood oxygenation and carbon dioxide removal.

IINN Stock Soars by 3.83% on March 12, 2024: Positive Momentum and Indicators Signal Potential Growth

On March 12, 2024, IINN stock showed a strong performance, with the price of shares increasing by $0.07 since the market last closed. This represents a significant 3.83% rise in value, with the stock closing at $1.90. In pre-market trading, the stock continued to show positive momentum, rising by an additional $0.14. One key indicator of the stock’s performance is its position relative to its 52-week range and its 200-day simple moving average. IINN is currently trading in the middle of its 52-week range, indicating that it is neither at its highest nor lowest point over the past year. Additionally, the stock is trading above its 200-day simple moving average, which is a positive sign for investors as it suggests a longer-term upward trend in the stock price. The strong price momentum and positive indicators for IINN on March 12th may be attributed to a variety of factors, such as positive news or developments related to the company, favorable market conditions, or increased investor interest in the stock. Investors who were holding IINN shares would have likely seen a significant increase in the value of their investment on this day. It is important for investors to carefully monitor stock performance and market trends to make informed decisions about buying, selling, or holding onto their investments. While past performance is not indicative of future results, the strong performance of IINN on March 12th may be a positive sign for the stock’s future trajectory.

IINN Stock Performance: Positive Growth in Net Income and EPS Signals Progress in Financial Health

On March 12, 2024, investors closely watched the performance of IINN stock as the company’s financial data was released. According to CNN Money, the total revenue for IINN was currently unavailable, making it difficult to gauge the overall financial health of the company. However, the net income figures provided some insight into the company’s profitability.

IINN reported a net income of -$10.27 million over the past year, which was an improvement of 39.41% compared to the previous year. In the most recent quarter, the net income was -$2.42 million, showing a 14.2% increase from the previous quarter. Despite the negative net income figures, the positive growth rates indicated that the company was making progress in improving its financial performance.

Earnings per share (EPS) is another important metric that investors look at to evaluate a company’s profitability. IINN reported an EPS of -$0.95 over the past year, representing a 70.22% increase from the previous year. In the most recent quarter, the EPS was -$0.21, showing a 12.06% increase from the previous quarter. The positive growth in EPS indicated that the company was becoming more efficient in generating earnings for its shareholders.

Overall, the financial data released on March 12, 2024, showed that IINN was making strides in improving its profitability. Despite the lack of total revenue figures, the positive growth rates in net income and EPS were encouraging signs for investors. It will be interesting to see how the company continues to perform in the coming quarters and whether it can sustain its growth momentum. Investors will be keeping a close eye on IINN stock as more data becomes available to assess the company’s financial health.

Tags: IINN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Oppenheimer Analyst Reaffirms Outperform Rating for Olema Pharmaceuticals

Biotechnology Stock Exchange

Analyst Reiterates Buy Rating on ZyVersa Therapeutics with Revised Price Target

AI-Medical

IceCure Medical Ltd Receives Notice of Allowance for Groundbreaking Cryogen Flow Control Patent

Recommended

Nike Stock

Nike Faces Critical Test as Quarterly Results Approach

6 months ago
Opendoor Stock

Opendoor Shares Plunge as Investor Confidence Evaporates

4 months ago
QuantumScape Stock

QuantumScape’s Stock Under Pressure: Can Innovation Outpace Market Doubts?

4 months ago
NASDAQ 100 Stock

Tech Giants Face Reality Check as AI Costs Rattle Nasdaq 100

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Trending

Dell Stock
AI & Quantum Computing

Dell’s Quantum Security Push Amidst AI-Driven Growth

by Kennethcix
March 25, 2026
0

Dell Technologies is fortifying its hardware portfolio for the dual challenges of quantum computing and artificial intelligence....

Gossamer Bio Stock

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Dell’s Quantum Security Push Amidst AI-Driven Growth
  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com